Prelude Therapeutics, Inc. (PRLD)
3.23
-0.02
(-0.77%)
USD |
NASDAQ |
Nov 20, 16:00
3.22
-0.01
(-0.31%)
After-Hours: 20:00
Prelude Therapeutics Price to Book Value : 2.082 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 2.082 |
| November 19, 2026 | 2.098 |
| November 18, 2026 | 2.127 |
| November 17, 2026 | 2.140 |
| November 16, 2026 | 2.198 |
| November 13, 2026 | 2.224 |
| November 12, 2026 | 2.269 |
| November 11, 2026 | 2.437 |
| November 10, 2026 | 2.424 |
| November 09, 2026 | 2.424 |
| November 06, 2026 | 2.321 |
| November 05, 2026 | 2.292 |
| November 04, 2026 | 2.630 |
| November 03, 2026 | 2.437 |
| November 02, 2026 | 2.476 |
| October 30, 2026 | 2.501 |
| October 29, 2026 | 2.643 |
| October 28, 2026 | 2.669 |
| October 27, 2026 | 2.501 |
| October 26, 2026 | 2.385 |
| October 23, 2026 | 2.340 |
| October 22, 2026 | 2.321 |
| October 21, 2026 | 2.353 |
| October 20, 2026 | 2.276 |
| October 19, 2026 | 2.185 |
| Date | Value |
|---|---|
| October 16, 2026 | 2.102 |
| October 15, 2026 | 2.140 |
| October 14, 2026 | 2.082 |
| October 13, 2026 | 2.295 |
| October 12, 2026 | 2.411 |
| October 09, 2026 | 2.508 |
| October 08, 2026 | 2.501 |
| October 07, 2026 | 2.469 |
| October 06, 2026 | 2.456 |
| October 05, 2026 | 2.430 |
| October 02, 2026 | 2.366 |
| October 01, 2026 | 2.443 |
| September 30, 2026 | 2.521 |
| September 29, 2026 | 2.362 |
| September 28, 2026 | 2.332 |
| September 25, 2026 | 2.311 |
| September 24, 2026 | 2.380 |
| September 23, 2026 | 2.570 |
| September 22, 2026 | 2.892 |
| September 21, 2026 | 2.803 |
| September 18, 2026 | 2.904 |
| September 17, 2026 | 2.726 |
| September 16, 2026 | 2.666 |
| September 15, 2026 | 2.696 |
| September 14, 2026 | 2.737 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Q32 Bio, Inc. | 0.8666 |
| Intellia Therapeutics, Inc. | 2.288 |
| Twist Bioscience Corp. | 7.89 |
| Beam Therapeutics, Inc. | 2.269 |
| Revolution Medicines, Inc. | 14.52 |
Price to Book Value Related Metrics
| PS Ratio | 12.99 |
| Price | 3.23 |
| Earnings Yield | -20.14% |
| Market Cap | 258.48M |